Form 4: Eliem Therapeutics EVP Exercises Stock Options
SEC Form 4 Filing
Valerie Morisset, EVP, R&D and CSO of Eliem Therapeutics, exercised stock options at nominal prices, resulting in the acquisition of common stock.
Summary
- On September 20, 2023, Valerie Morisset, the EVP, R&D and CSO of Eliem Therapeutics, Inc. (ELYM), exercised stock options.
- Morisset acquired 5,431 shares of common stock at a price of $0.002 per share and 15,297 shares of common stock at a price of $0.0002 per share.
- Following these transactions, Morisset directly owns 487,460 shares of Eliem Therapeutics common stock.
- The stock options exercised were granted with vesting schedules commencing on April 1, 2019, and February 26, 2021, respectively, vesting monthly over four years.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock option exercises. The executive's action could be interpreted as a positive signal, but it's not definitively bullish.
Positives
- The exercise of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the beneficial ownership of Eliem Therapeutics' securities by one of its executives.
Stakeholder Impact
- The exercise of stock options could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/01/2019 | April 2019 Vesting Commencement Date for 5,431 shares. |
| 02/26/2021 | February 2021 Vesting Commencement Date for 15,297 shares. |
| 09/20/2023 | Date of stock option exercise and acquisition of shares. |
| 02/03/2030 | Expiration date for stock options related to the April 2019 Vesting Commencement Date. |
| 02/25/2031 | Expiration date for stock options related to the February 2021 Vesting Commencement Date. |
| 03/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.